The auditor in Sydney has been replaced by one in Perth but yes I too would like a detailed breakdown of ARV expenditure over the last 18 months.
From memory NOVO decided not to do assay's on Purdys "small samples" or that was the line from memory. IMO NOVO was never going to do anything to give another free kick to ARV or an of the other Pilbara players. Why would they?
The CN is the killer and needs cleaned up for sure. Decisive action (probably unpleasant) on that item would be a major positive IMO.
Ann: Management Changes, page-112
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ARV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.91M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.3¢ | $258.1K | 17.20M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1435482 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| ARV (ASX) Chart |